Medical Care

Global Genetic Modification Therapies Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Genetic Modification Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Modification Therapies.
The Genetic Modification Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetic Modification Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Modification Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
4D Molecular Therapeutics
Abeona Therapeutics
Allergan
American Gene Technologies
Merck Millipore
AbbVie
Segment by Type
Gene Therapies
Genetically Modified Cell Therapies
RNA Therapies
Gene Editing
Segment by Application
Hospitals
Diagnostics and Testing Laboratories
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Modification Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Modification Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Therapies
1.2.3 Genetically Modified Cell Therapies
1.2.4 RNA Therapies
1.2.5 Gene Editing
1.3 Market by Application
1.3.1 Global Genetic Modification Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Modification Therapies Market Perspective (2020-2031)
2.2 Global Genetic Modification Therapies Growth Trends by Region
2.2.1 Global Genetic Modification Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genetic Modification Therapies Historic Market Size by Region (2020-2025)
2.2.3 Genetic Modification Therapies Forecasted Market Size by Region (2026-2031)
2.3 Genetic Modification Therapies Market Dynamics
2.3.1 Genetic Modification Therapies Industry Trends
2.3.2 Genetic Modification Therapies Market Drivers
2.3.3 Genetic Modification Therapies Market Challenges
2.3.4 Genetic Modification Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Modification Therapies Players by Revenue
3.1.1 Global Top Genetic Modification Therapies Players by Revenue (2020-2025)
3.1.2 Global Genetic Modification Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genetic Modification Therapies Revenue
3.4 Global Genetic Modification Therapies Market Concentration Ratio
3.4.1 Global Genetic Modification Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Modification Therapies Revenue in 2024
3.5 Global Key Players of Genetic Modification Therapies Head office and Area Served
3.6 Global Key Players of Genetic Modification Therapies, Product and Application
3.7 Global Key Players of Genetic Modification Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Modification Therapies Breakdown Data by Type
4.1 Global Genetic Modification Therapies Historic Market Size by Type (2020-2025)
4.2 Global Genetic Modification Therapies Forecasted Market Size by Type (2026-2031)
5 Genetic Modification Therapies Breakdown Data by Application
5.1 Global Genetic Modification Therapies Historic Market Size by Application (2020-2025)
5.2 Global Genetic Modification Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genetic Modification Therapies Market Size (2020-2031)
6.2 North America Genetic Modification Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genetic Modification Therapies Market Size by Country (2020-2025)
6.4 North America Genetic Modification Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Modification Therapies Market Size (2020-2031)
7.2 Europe Genetic Modification Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genetic Modification Therapies Market Size by Country (2020-2025)
7.4 Europe Genetic Modification Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Modification Therapies Market Size (2020-2031)
8.2 Asia-Pacific Genetic Modification Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genetic Modification Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Genetic Modification Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Modification Therapies Market Size (2020-2031)
9.2 Latin America Genetic Modification Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genetic Modification Therapies Market Size by Country (2020-2025)
9.4 Latin America Genetic Modification Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Modification Therapies Market Size (2020-2031)
10.2 Middle East & Africa Genetic Modification Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genetic Modification Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Genetic Modification Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 4D Molecular Therapeutics
11.1.1 4D Molecular Therapeutics Company Details
11.1.2 4D Molecular Therapeutics Business Overview
11.1.3 4D Molecular Therapeutics Genetic Modification Therapies Introduction
11.1.4 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2020-2025)
11.1.5 4D Molecular Therapeutics Recent Development
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Company Details
11.2.2 Abeona Therapeutics Business Overview
11.2.3 Abeona Therapeutics Genetic Modification Therapies Introduction
11.2.4 Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2020-2025)
11.2.5 Abeona Therapeutics Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Genetic Modification Therapies Introduction
11.3.4 Allergan Revenue in Genetic Modification Therapies Business (2020-2025)
11.3.5 Allergan Recent Development
11.4 American Gene Technologies
11.4.1 American Gene Technologies Company Details
11.4.2 American Gene Technologies Business Overview
11.4.3 American Gene Technologies Genetic Modification Therapies Introduction
11.4.4 American Gene Technologies Revenue in Genetic Modification Therapies Business (2020-2025)
11.4.5 American Gene Technologies Recent Development
11.5 Merck Millipore
11.5.1 Merck Millipore Company Details
11.5.2 Merck Millipore Business Overview
11.5.3 Merck Millipore Genetic Modification Therapies Introduction
11.5.4 Merck Millipore Revenue in Genetic Modification Therapies Business (2020-2025)
11.5.5 Merck Millipore Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Genetic Modification Therapies Introduction
11.6.4 AbbVie Revenue in Genetic Modification Therapies Business (2020-2025)
11.6.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Genetic Modification Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene Therapies
Table 3. Key Players of Genetically Modified Cell Therapies
Table 4. Key Players of RNA Therapies
Table 5. Key Players of Gene Editing
Table 6. Global Genetic Modification Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Genetic Modification Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Genetic Modification Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Genetic Modification Therapies Market Share by Region (2020-2025)
Table 10. Global Genetic Modification Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Genetic Modification Therapies Market Share by Region (2026-2031)
Table 12. Genetic Modification Therapies Market Trends
Table 13. Genetic Modification Therapies Market Drivers
Table 14. Genetic Modification Therapies Market Challenges
Table 15. Genetic Modification Therapies Market Restraints
Table 16. Global Genetic Modification Therapies Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Genetic Modification Therapies Market Share by Players (2020-2025)
Table 18. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Modification Therapies as of 2024)
Table 19. Ranking of Global Top Genetic Modification Therapies Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Genetic Modification Therapies Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Genetic Modification Therapies, Headquarters and Area Served
Table 22. Global Key Players of Genetic Modification Therapies, Product and Application
Table 23. Global Key Players of Genetic Modification Therapies, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genetic Modification Therapies Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Genetic Modification Therapies Revenue Market Share by Type (2020-2025)
Table 27. Global Genetic Modification Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Genetic Modification Therapies Revenue Market Share by Type (2026-2031)
Table 29. Global Genetic Modification Therapies Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Genetic Modification Therapies Revenue Market Share by Application (2020-2025)
Table 31. Global Genetic Modification Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Genetic Modification Therapies Revenue Market Share by Application (2026-2031)
Table 33. North America Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Genetic Modification Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Genetic Modification Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Genetic Modification Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Genetic Modification Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Genetic Modification Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Genetic Modification Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Genetic Modification Therapies Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Genetic Modification Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Genetic Modification Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Genetic Modification Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Genetic Modification Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 48. 4D Molecular Therapeutics Company Details
Table 49. 4D Molecular Therapeutics Business Overview
Table 50. 4D Molecular Therapeutics Genetic Modification Therapies Product
Table 51. 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2020-2025) & (US$ Million)
Table 52. 4D Molecular Therapeutics Recent Development
Table 53. Abeona Therapeutics Company Details
Table 54. Abeona Therapeutics Business Overview
Table 55. Abeona Therapeutics Genetic Modification Therapies Product
Table 56. Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2020-2025) & (US$ Million)
Table 57. Abeona Therapeutics Recent Development
Table 58. Allergan Company Details
Table 59. Allergan Business Overview
Table 60. Allergan Genetic Modification Therapies Product
Table 61. Allergan Revenue in Genetic Modification Therapies Business (2020-2025) & (US$ Million)
Table 62. Allergan Recent Development
Table 63. American Gene Technologies Company Details
Table 64. American Gene Technologies Business Overview
Table 65. American Gene Technologies Genetic Modification Therapies Product
Table 66. American Gene Technologies Revenue in Genetic Modification Therapies Business (2020-2025) & (US$ Million)
Table 67. American Gene Technologies Recent Development
Table 68. Merck Millipore Company Details
Table 69. Merck Millipore Business Overview
Table 70. Merck Millipore Genetic Modification Therapies Product
Table 71. Merck Millipore Revenue in Genetic Modification Therapies Business (2020-2025) & (US$ Million)
Table 72. Merck Millipore Recent Development
Table 73. AbbVie Company Details
Table 74. AbbVie Business Overview
Table 75. AbbVie Genetic Modification Therapies Product
Table 76. AbbVie Revenue in Genetic Modification Therapies Business (2020-2025) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
Table 81. Authors List of This Report


List of Figures
Figure 1. Genetic Modification Therapies Picture
Figure 2. Global Genetic Modification Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genetic Modification Therapies Market Share by Type: 2024 VS 2031
Figure 4. Gene Therapies Features
Figure 5. Genetically Modified Cell Therapies Features
Figure 6. RNA Therapies Features
Figure 7. Gene Editing Features
Figure 8. Global Genetic Modification Therapies Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Genetic Modification Therapies Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Diagnostics and Testing Laboratories Case Studies
Figure 12. Academic and Research Organizations Case Studies
Figure 13. Others Case Studies
Figure 14. Genetic Modification Therapies Report Years Considered
Figure 15. Global Genetic Modification Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Genetic Modification Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Genetic Modification Therapies Market Share by Region: 2024 VS 2031
Figure 18. Global Genetic Modification Therapies Market Share by Players in 2024
Figure 19. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Modification Therapies as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Genetic Modification Therapies Revenue in 2024
Figure 21. North America Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Genetic Modification Therapies Market Share by Country (2020-2031)
Figure 23. United States Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Genetic Modification Therapies Market Share by Country (2020-2031)
Figure 27. Germany Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Genetic Modification Therapies Market Share by Region (2020-2031)
Figure 35. China Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Genetic Modification Therapies Market Share by Country (2020-2031)
Figure 43. Mexico Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Genetic Modification Therapies Market Share by Country (2020-2031)
Figure 47. Turkey Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Genetic Modification Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. 4D Molecular Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2020-2025)
Figure 51. Abeona Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2020-2025)
Figure 52. Allergan Revenue Growth Rate in Genetic Modification Therapies Business (2020-2025)
Figure 53. American Gene Technologies Revenue Growth Rate in Genetic Modification Therapies Business (2020-2025)
Figure 54. Merck Millipore Revenue Growth Rate in Genetic Modification Therapies Business (2020-2025)
Figure 55. AbbVie Revenue Growth Rate in Genetic Modification Therapies Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies